Center for Neurovirology, Department of Neuroscience, Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.
Int J Mol Sci. 2020 Aug 28;21(17):6236. doi: 10.3390/ijms21176236.
Cancer is the second leading cause of mortality worldwide. The study of DNA tumor-inducing viruses and their oncoproteins as a causative agent in cancer initiation and tumor progression has greatly enhanced our understanding of cancer cell biology. The initiation of oncogenesis is a complex process. Specific gene mutations cause functional changes in the cell that ultimately result in the inability to regulate cell differentiation and proliferation effectively. The human neurotropic Polyomavirus JC (JCV) belongs to the family and it is the causative agent of progressive multifocal leukoencephalopathy (PML), which is a fatal neurodegenerative disease in an immunosuppressed state. Sero-epidemiological studies have indicated JCV infection is prevalent in the population (85%) and that initial infection usually occurs during childhood. The JC virus has small circular, double-stranded DNA that includes coding sequences for viral early and late proteins. Persistence of the virus in the brain and other tissues, as well as its potential to transform cells, has made it a subject of study for its role in brain tumor development. Earlier observation of malignant astrocytes and oligodendrocytes in PML, as well as glioblastoma formation in non-human primates inoculated with JCV, led to the hypothesis that JCV plays a role in central nervous system (CNS) tumorigenesis. Some studies have reported the presence of both JC viral DNA and its proteins in several primary brain tumor specimens. The discovery of new Polyomaviruses such as the Merkel cell Polyomavirus, which is associated with Merkel cell carcinomas in humans, ignited our interest in the role of the JC virus in CNS tumors. The current evidence known about JCV and its effects, which are sufficient to produce tumors in animal models, suggest it can be a causative factor in central nervous system tumorigenesis. However, there is no clear association between JCV presence in CNS and its ability to initiate CNS cancer and tumor formation in humans. In this review, we will discuss the correlation between JCV and tumorigenesis of CNS in animal models, and we will give an overview of the current evidence for the JC virus's role in brain tumor formation.
癌症是全球第二大死亡原因。对诱导肿瘤发生的 DNA 病毒及其癌蛋白的研究作为癌症起始和肿瘤进展的一个致病因素,极大地增进了我们对癌细胞生物学的理解。致癌作用的起始是一个复杂的过程。特定的基因突变导致细胞的功能改变,最终导致细胞无法有效调节细胞分化和增殖。人类亲神经性多瘤病毒 JC(JCV)属于家族,是进行性多灶性白质脑病(PML)的病原体,PML 是一种在免疫抑制状态下致命的神经退行性疾病。血清流行病学研究表明 JCV 感染在人群中普遍存在(85%),并且初始感染通常发生在儿童时期。JC 病毒有小的圆形双链 DNA,包括病毒早期和晚期蛋白的编码序列。病毒在大脑和其他组织中的持续存在及其转化细胞的潜力,使其成为研究其在脑肿瘤发展中的作用的对象。在 PML 中早期观察到恶性星形胶质细胞和少突胶质细胞,以及用 JCV 接种的非人类灵长类动物中形成的神经胶质瘤,导致了 JCV 在中枢神经系统(CNS)肿瘤发生中起作用的假说。一些研究报告了几种原发性脑肿瘤标本中存在 JC 病毒 DNA 和其蛋白。发现新的多瘤病毒,如与人类 Merkel 细胞癌相关的 Merkel 细胞多瘤病毒,激发了我们对 JCV 在中枢神经系统肿瘤中的作用的兴趣。目前已知的关于 JCV 及其作用的证据足以在动物模型中产生肿瘤,表明它可能是中枢神经系统肿瘤发生的一个致病因素。然而,在 CNS 中 JCV 的存在与其引发 CNS 癌症和肿瘤形成的能力之间没有明确的关联。在这篇综述中,我们将讨论 JCV 与动物模型中 CNS 肿瘤发生的相关性,并概述 JCV 在脑肿瘤形成中的作用的现有证据。